Bioequivalence study of two losartan tablet formulations with special emphasis on cardiac safety. (Record no. 21739411)

MARC details
000 -LEADER
fixed length control field 01532 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516091013.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201207s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0946-1965
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.5414/cp201521
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Khandave, Suhas S
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20120724
245 00 - TITLE STATEMENT
Title Bioequivalence study of two losartan tablet formulations with special emphasis on cardiac safety.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. International journal of clinical pharmacology and therapeutics
Date of publication, distribution, etc. May 2012
300 ## - PHYSICAL DESCRIPTION
Extent 349-59 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Angiotensin II Type 1 Receptor Blockers
General subdivision pharmacokinetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antihypertensive Agents
General subdivision pharmacokinetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chemistry, Pharmaceutical
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cross-Over Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Heart
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Losartan
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Solubility
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tablets
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Therapeutic Equivalency
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sawant, Satish V
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sahane, Rakhi V
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Murthi, Vivekanand
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dhanure, Shivanand S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Surve, Pradeep G
773 0# - HOST ITEM ENTRY
Title International journal of clinical pharmacology and therapeutics
Related parts vol. 50
-- no. 5
-- p. 349-59
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.5414/cp201521">https://doi.org/10.5414/cp201521</a>
Public note Available from publisher's website

No items available.